A. Doyon Et Al. , "Impact of recombinant growth hormone (rGH) therapy on bone metabolism in children with chronic kidney disease (CKD): Findings from the 4C Study," PEDIATRIC NEPHROLOGY , vol.28, no.8, pp.1369, 2013
Doyon, A. Et Al. 2013. Impact of recombinant growth hormone (rGH) therapy on bone metabolism in children with chronic kidney disease (CKD): Findings from the 4C Study. PEDIATRIC NEPHROLOGY , vol.28, no.8 , 1369.
Doyon, A., Fischer, D., KARABAY BAYAZIT, A., Canpolat, N., Sozeri, B., Bacchetta, J., ... Gondan, M.(2013). Impact of recombinant growth hormone (rGH) therapy on bone metabolism in children with chronic kidney disease (CKD): Findings from the 4C Study. PEDIATRIC NEPHROLOGY , vol.28, no.8, 1369.
Doyon, Anke Et Al. "Impact of recombinant growth hormone (rGH) therapy on bone metabolism in children with chronic kidney disease (CKD): Findings from the 4C Study," PEDIATRIC NEPHROLOGY , vol.28, no.8, 1369, 2013
Doyon, Anke Et Al. "Impact of recombinant growth hormone (rGH) therapy on bone metabolism in children with chronic kidney disease (CKD): Findings from the 4C Study." PEDIATRIC NEPHROLOGY , vol.28, no.8, pp.1369, 2013
Doyon, A. Et Al. (2013) . "Impact of recombinant growth hormone (rGH) therapy on bone metabolism in children with chronic kidney disease (CKD): Findings from the 4C Study." PEDIATRIC NEPHROLOGY , vol.28, no.8, p.1369.
@article{article, author={Anke Doyon Et Al. }, title={Impact of recombinant growth hormone (rGH) therapy on bone metabolism in children with chronic kidney disease (CKD): Findings from the 4C Study}, journal={PEDIATRIC NEPHROLOGY}, year=2013, pages={1369} }